PTPN11 and esophageal squamous cell carcinoma: Not surprisingly, SHP2 suppressed the proliferation of esophageal squamous cell cancer by inhibiting STAT3 phosphorylation, and depletion of SHP2 resulted in the attenuation of cisplatin sensitivity [82].